Status:
TERMINATED
Effectiveness of Electrical Neurostimulation in Cyclic Vomiting Syndrome.
Lead Sponsor:
Medical College of Wisconsin
Conditions:
Cyclic Vomiting Syndrome
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
We hypothesize that 1) Neurostimulation via a novel auricular percutaneous electrical nerve field stimulation (PENFS) device is a safe, non-invasive opioid-sparing alternative therapy for severe abdom...
Detailed Description
Opioid use in CVS and the critical need for opioid sparing therapy Given the lack of knowledge about pathophysiology and evidence-based therapies, patients are often hospitalized to treat symptoms of...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- • Patients who meet Rome criteria for cyclic vomiting syndrome and are in an acute episode.
- Exclusion Criteria:
- Developmental delay
- Non-English speaking patients
- Pregnancy
- Any implanted electrical device
- Any significant dermatological/infectious condition of the ear
Exclusion
Key Trial Info
Start Date :
April 23 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 9 2021
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT04721171
Start Date
April 23 2019
End Date
February 9 2021
Last Update
March 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical College of Wisconsin
Milwaukee, Wisconsin, United States, 53226